GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Perrigo Co PLC (LTS:0Y5E) » Definitions » Cyclically Adjusted Revenue per Share

Perrigo Co (LTS:0Y5E) Cyclically Adjusted Revenue per Share : $37.96 (As of Mar. 2024)


View and export this data going back to 2018. Start your Free Trial

What is Perrigo Co Cyclically Adjusted Revenue per Share?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

Perrigo Co's adjusted revenue per share for the three months ended in Mar. 2024 was $7.864. Add all the adjusted revenue per share for the past 10 years together and divide the count will get our Cyclically Adjusted Revenue per Share, which is $37.96 for the trailing ten years ended in Mar. 2024.

During the past 12 months, Perrigo Co's average Cyclically Adjusted Revenue Growth Rate was -0.20% per year. During the past 3 years, the average Cyclically Adjusted Revenue Growth Rate was 4.10% per year. During the past 5 years, the average Cyclically Adjusted Revenue Growth Rate was 3.00% per year. During the past 10 years, the average Cyclically Adjusted Revenue Growth Rate was 4.90% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Revenue Growth Rate using Cyclically Adjusted Revenue per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Revenue Growth Rate of Perrigo Co was 12.70% per year. The lowest was 2.20% per year. And the median was 4.70% per year.

As of today (2024-06-05), Perrigo Co's current stock price is $27.04. Perrigo Co's Cyclically Adjusted Revenue per Share for the quarter that ended in Mar. 2024 was $37.96. Perrigo Co's Cyclically Adjusted PS Ratio of today is 0.71.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of Perrigo Co was 7.64. The lowest was 0.69. And the median was 1.80.


Perrigo Co Cyclically Adjusted Revenue per Share Historical Data

The historical data trend for Perrigo Co's Cyclically Adjusted Revenue per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Perrigo Co Cyclically Adjusted Revenue per Share Chart

Perrigo Co Annual Data
Trend Jun14 Jun15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted Revenue per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 35.59 33.82 35.82 36.00 37.95

Perrigo Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Cyclically Adjusted Revenue per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 37.34 38.13 38.40 37.95 37.96

Competitive Comparison of Perrigo Co's Cyclically Adjusted Revenue per Share

For the Drug Manufacturers - Specialty & Generic subindustry, Perrigo Co's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Perrigo Co's Cyclically Adjusted PS Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Perrigo Co's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Perrigo Co's Cyclically Adjusted PS Ratio falls into.



Perrigo Co Cyclically Adjusted Revenue per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

What is Cyclically Adjusted Revenue per Share? How do we calculate Cyclically Adjusted Revenue per Share?

Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Revenue per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the revenue per share from 2001 through 2010.

We adjusted the 2001 revenue per share data with the total inflation from 2001 through 2010 to the equivalent revenue in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's revenue is $1 a share in 2001, then the 2001's equivalent revenue in 2010 is $1.4 a share. If Wal-Mart's revenue is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 revenue in 2010 is $1.35. So on and so forth, you get the equivalent revenue per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Perrigo Co's adjusted Revenue per Share data for the three months ended in Mar. 2024 was:

Adj_RevenuePerShare= Revenue per Share /CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=7.864/120.9901*120.9901
=7.864

Current CPI (Mar. 2024) = 120.9901.

Perrigo Co Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201406 7.433 100.773 8.924
201409 7.080 100.474 8.526
201412 7.834 99.576 9.519
201503 7.451 99.975 9.017
201506 7.872 100.573 9.470
201509 9.154 100.274 11.045
201512 9.823 99.676 11.923
201603 9.659 99.676 11.724
201606 9.361 101.072 11.206
201609 8.804 100.274 10.623
201612 9.271 99.676 11.253
201703 8.315 100.374 10.023
201706 8.639 100.673 10.382
201709 8.689 100.474 10.463
201712 9.036 100.075 10.924
201803 8.607 100.573 10.354
201806 8.554 101.072 10.240
201809 8.247 101.371 9.843
201812 8.775 100.773 10.535
201903 8.623 101.670 10.262
201906 8.418 102.168 9.969
201909 8.707 102.268 10.301
201912 2.597 102.068 3.078
202003 7.890 102.367 9.325
202006 6.900 101.769 8.203
202009 7.289 101.072 8.725
202012 7.727 101.072 9.250
202103 7.504 102.367 8.869
202106 7.344 103.364 8.596
202109 7.793 104.859 8.992
202112 8.252 106.653 9.361
202203 8.019 109.245 8.881
202206 8.334 112.779 8.941
202209 8.174 113.504 8.713
202212 8.570 115.436 8.982
202303 8.760 117.609 9.012
202306 8.734 119.662 8.831
202309 8.209 120.749 8.225
202312 8.532 120.749 8.549
202403 7.864 120.990 7.864

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.


Perrigo Co  (LTS:0Y5E) Cyclically Adjusted Revenue per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Revenue per Share may underestimate the company's revenue. Cyclically Adjusted PS Ratio can seem to be too high even the actual PS Ratio is low.

For the Cyclically Adjusted PS Ratio, the revenue per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/S calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PS Ratio is also called CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

Perrigo Co's Cyclically Adjusted PS Ratio of today is calculated as

Cyclically Adjusted PS Ratio=Share Price/Cyclically Adjusted Revenue per Share
=27.04/37.96
=0.71

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of Perrigo Co was 7.64. The lowest was 0.69. And the median was 1.80.


Be Aware

Cyclically Adjusted PS Ratio works better for cyclical companies. It gives you a better idea on the company's real revenue value.


Perrigo Co Cyclically Adjusted Revenue per Share Related Terms

Thank you for viewing the detailed overview of Perrigo Co's Cyclically Adjusted Revenue per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


Perrigo Co (LTS:0Y5E) Business Description

Industry
Traded in Other Exchanges
Address
The Sharp Building, Hogan Place, Dublin, IRL, D02 TY74
Perrigo is one of the largest consumer health companies in the world. Since 2018, Perrigo divested its animal health and generic pharmaceuticals businesses to solely focus on consumer self-care. In North America (two thirds of total sales), the firm's product mix is anchored in private-label consumer health goods, which are sold to major retailers like Walmart, Amazon, Costco, and CVS. Perrigo also plays in Europe, Australia, and parts of Asia where it primarily generates revenue through its national brands, including Compeed, Solpadeine, Coldrex, and ellaOne.

Perrigo Co (LTS:0Y5E) Headlines

No Headlines